Target intelligence / Profile preview

Streptococcus mutans and other cariogenic oral bacteria (S. mutans)

Target
S. mutans
Molecular classification
Other
01

Overview

Streptococcus mutans and other cariogenic oral bacteria, such as Lactobacillus and Actinomyces species, are the primary microbial drivers of dental caries (tooth decay) [1]. These Gram-positive bacteria colonize the tooth surface by forming complex biofilms known as dental plaque, utilizing dietary sucrose to produce extracellular polysaccharides that facilitate adhesion [2]. Their pathogenicity is defined by acidogenicity—the fermentation of carbohydrates into lactic acid—and aciduricity, which allows them to survive in the resulting low-pH environment that demineralizes dental enamel [1, 2]. Beyond oral health, S. mutans is a significant cause of infective endocarditis if it enters the systemic circulation [4].\n\nTherapeutic strategies focus on reducing bacterial load and inhibiting acid production using agents like fluoride and chlorhexidine [3, 5]. Fluoride acts by inhibiting the bacterial enzyme enolase and promoting the remineralization of tooth surfaces [3]. Antiseptics like chlorhexidine disrupt bacterial cell membranes, while sugar alcohols like xylitol interfere with bacterial metabolism to prevent the accumulation of plaque [1, 5]. These interventions aim to manage the oral microbiome and prevent the progression of dental disease [1].

Other names
Cariogenic bacteriaDental plaque bacteriaAcidogenic oral bacteriaOral streptococci
02

Mechanism of action

Inhibition of bacterial metabolism and disruption of biofilm integrity.

03

Biological functions

Other
04

Disease associations

InfectionOther
05

Safety considerations

Antimicrobial resistanceOral dysbiosisTooth stainingDental fluorosis
06

Interacting drugs

Fluoride

5 more in the full profile.

07

Biomarkers

Salivary Streptococcus mutans levelsPlaque pHLactic acid concentration

Beyond the preview

Go deeper on Streptococcus mutans and other cariogenic oral bacteria (S. mutans).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus mutans and other cariogenic oral bacteria (S. mutans).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call